- Home
- RNGR vs ALDX Comparison
RNGR vs ALDX Comparison
Compare RNGR & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNGR | ALDX |
|---|---|---|
| Founded | 2017 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 364.1M | 317.7M |
| IPO Year | 2017 | 2014 |
Fundamental Metrics
Financial Performance| Metric | RNGR | ALDX |
|---|---|---|
| Price | $16.44 | $4.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $17.00 | $9.50 |
| AVG Volume (30 Days) | 121.8K | ★ 827.6K |
| Earning Date | 06-15-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.41% | N/A |
| EPS Growth | N/A | ★ 40.43 |
| EPS | ★ 0.54 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.56 | $123.43 |
| P/E Ratio | $31.44 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.56 | $1.18 |
| 52 Week High | $17.89 | $7.19 |
Technical Indicators
Market Signals| Indicator | RNGR | ALDX |
|---|---|---|
| Relative Strength Index (RSI) | 48.75 | 42.44 |
| Support Level | $13.55 | $4.74 |
| Resistance Level | $17.25 | $5.70 |
| Average True Range (ATR) | 0.65 | 0.33 |
| MACD | -0.10 | -0.07 |
| Stochastic Oscillator | 17.32 | 30.55 |
Price Performance
Historical ComparisonAbout RNGR Ranger Energy Services Inc.
Ranger Energy Services Inc is a provider of onshore high-specification (high-spec) well service rigs, wireline services, and additional processing solutions and ancillary services in the United States. It offers a range of well-site services to U.S. exploration and production (E&P) companies that are fundamental to establishing and enhancing the flow of oil and natural gas throughout the productive life of a well. The segments of the group are High Specification Rigs, Wireline Services and Processing Solutions, and Ancillary Services, of which key revenue is derived from the High Specification Rigs segment.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.